He shared the following tip with Becker’s Hospital Review.
“The use of specialty medications continues to increase, with experts projecting them to account for 50 percent of total drug spend by 2018. By establishing an in-house specialty pharmacy, health systems will not only drive significant revenue, but also create a coordinated care model that helps ensure quality care and better outcomes for patients with chronic illnesses and complex medical conditions.
Meanwhile, an ambulatory pharmacy — which can serve as the prescription ‘hub’ for discharged patients and employees — allows pharmacists to monitor a patient’s medication needs across the care continuum and provide consistent support. Ambulatory pharmacy programs keep patients engaged, drive improved medication adherence to reduce the risk of readmission and increase revenue.
Finally, reinforcing and streamlining 340B systems and processes can strengthen a health system’s regulatory profile, increase audit readiness and expand access to affordable medications for at-risk patients.”
More articles on supply chain:
FDA greenlights treatment for giant cell arteritis: 3 things to know
5 similarities between the 34 most expensive novel drugs
NY Medicaid program to inspect drugmakers who don’t share discounts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.